Fresenius Medical Care Holdings, Inc. Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician s prescription. Both concentrates are formulated for use in 45X proportioning systems which proportion a nominal ratio of 1 : 1.72 : 42.28 (acid : bicarbonate : water) to generate dialysate. The dialysate is intended to be pumped through a dialyzer, creating an osmotic gradient acro Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician s prescription. Both concentrates are formulated for use in 45X proportioning systems which proportion a nominal ratio of 1 : 1.72 : 42.28 (acid : bicarbonate : water) to generate dialysate. The dialysate is intended to be pumped through a dialyzer, creating an osmotic gradient acro
Brand
Fresenius Medical Care Holdings, Inc.
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Lot Number/UDI: (1) 21ATGF013 (01)00884086110135 0FD3251-3B (2) 20SXGF010 (01)00840861101597 0FD3251-3B (3) 20SXGF013 (01)00840861101597
Fresenius Medical Care Holdings, Inc. is recalling Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as one due to Exposed to freezing temperatures due to refrigerated truck malfunctions. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Exposed to freezing temperatures due to refrigerated truck malfunctions
Recommended Action
Per FDA guidance
Fresenius issued telephone script communication on April 28.2021 stating reason for recall, heath risk and action to take: Tell them you already contacted their Home Therapy Nurse to alert them that you would be calling them. o The purpose of my call today is that you received a delivery from us on (either Feb 22nd or Feb 23rd). o The truck you received a delivery from had a temperature malfunction due to the bad storms Texas experienced back in February. This caused the product you were delivered to be exposed to freezing or near freezing temperatures for about 3 hours. o o I see you received on . o (if received any PD SOLUTION/SALINE/or CONCENTRATES): Explain that the solutions inside their product are not affected and that we have freeze/thaw studies that prove this. Explain that due to the freezing temperatures, the packaging may become compromised, and they may have seen leaks. For the other products such as Hand Sanitizer and other ancillary products, again, the product could be compromised according to their packaging requirements listed on their packaging. o We are giving you the opportunity to return these products if you choose to do so at this time. o If returning product(s): o Fill out RGA spreadsheet with customer information including how much product they are returning (include lot# and amount returning). Driver will pick up returned products on their next scheduled visit. Fresenius Corrections and Removals Rep: Email Post Market Surveillance to open a complaint against product. o If not returning product(s): o Thank them for their time and reiterate to always inspect their packaging for leaks as this is what they are trained to do anyways from their Home Therapies Nurse. If you have any questions call 781-699-2243 or email: beth.st.germain@fmc-na.com
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
TX
Page updated: Jan 10, 2026